0001520649-12-000004.txt : 20120120
0001520649-12-000004.hdr.sgml : 20120120
20120120162702
ACCESSION NUMBER: 0001520649-12-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120118
FILED AS OF DATE: 20120120
DATE AS OF CHANGE: 20120120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sayiner Necip
CENTRAL INDEX KEY: 0001338515
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29823
FILM NUMBER: 12537279
MAIL ADDRESS:
STREET 1: 400 W CESAR CHAVEZ
CITY: AUSTIN
STATE: TX
ZIP: 78701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SILICON LABORATORIES INC
CENTRAL INDEX KEY: 0001038074
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 742793174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 W CESAR CHAVEZ
CITY: AUSTIN
STATE: TX
ZIP: 78701
BUSINESS PHONE: 5124168500
MAIL ADDRESS:
STREET 1: 400 W CESAR CHAVEZ
CITY: AUSTIN
STATE: TX
ZIP: 78701
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2012-01-18
0
0001038074
SILICON LABORATORIES INC
SLAB
0001338515
Sayiner Necip
400 W CESAR CHAVEZ
AUSTIN
TX
78701
1
1
0
0
President & CEO
Common Stock, $0.0001 par value
2012-01-18
4
M
0
25000
32.27
A
294356
D
Common Stock, $0.0001 par value
2012-01-18
4
S
0
29500
44.82
D
264856
D
Common Stock, $0.0001 par value
2012-01-18
4
S
0
800
43.5413
D
264056
D
Common Stock, $0.0001 par value
2012-01-18
4
S
0
2635
44.171
D
261421
D
Non-Qualified Stock Option (right to buy)
32.27
2012-01-18
4
M
0
25000
D
2006-09-14
2015-09-14
Common Stock, $0.0001 par value
25000
240000
D
Includes shares purchased by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the Plan's two most recent semi-annual purchase dates.
Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan.
Price represents the weighted average selling price. Prices range between $42.78 and $43.77.
Price represents the weighted average selling price. Prices range between $43.80 and $44.65.
Option vests and becomes exercisable with respect to (i) twenty percent (20%) of the option shares upon the date exercisable and (ii) the balance of the option shares in a series of forty-eight (48) successive monthly installments over the forty-eight (48) month period measured from the date exercisable.
Not applicable per instruction 4(c)(iii).
Necip Sayiner
2012-01-20